Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADIT cluster crossover study
NL-OMON40692Phase 4Active, not recruiting
- Sponsor
- Population Health Research Institute
- Start
- Oct 2014
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefazolin, vancomycin, cefalexin, cefadroxil and clindamycin in Cardiac Device Infection (CIEDI) (2 arms), sponsored by Population Health Research Institute. Started Oct 2014; status: active, not recruiting.
02
Drugs
cefazolinvancomycincefalexincefadroxilclindamycin
03
Conditions
Cardiac Device Infection (CIEDI)
Beyond the preview
Go deeper on NL-OMON40692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40692.